Real-world effectiveness of original BNT162b2 mRNA COVID-19 against symptomatic Omicron infection among children 5-11 years of age in Brazil: A prospective test-negative design study.
Saved in:
| Title: | Real-world effectiveness of original BNT162b2 mRNA COVID-19 against symptomatic Omicron infection among children 5-11 years of age in Brazil: A prospective test-negative design study. |
|---|---|
| Authors: | Rodrigues CO; Faculty of Medicine, Campus Toledo, Federal University of Paraná (UFPR), Brazil., Spinardi J; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Rosa RG; Internal Medicine Department, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil; Research Unit, Inova Medical, Porto Alegre, RS, Brazil; Research Institute, HMV, Porto Alegre, RS, Brazil. Electronic address: regisgoulartrosa@gmail.com., Falavigna M; Research Unit, Inova Medical, Porto Alegre, RS, Brazil; Research Institute, HMV, Porto Alegre, RS, Brazil; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada., de Souza EM; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Manfio JL; Research Institute, HMV, Porto Alegre, RS, Brazil., de Souza AP; Research Institute, HMV, Porto Alegre, RS, Brazil., de Araujo CLP; Research Institute, HMV, Porto Alegre, RS, Brazil., Cohen M; Research Institute, HMV, Porto Alegre, RS, Brazil; Federal University of Rio Grande do Sul (UFRGS), Brazil., Barbosa GRGDV; Research Institute, HMV, Porto Alegre, RS, Brazil., Silva FKR; Research Institute, HMV, Porto Alegre, RS, Brazil., Sganzerla D; Research Institute, HMV, Porto Alegre, RS, Brazil., da Silva MMD; Research Institute, HMV, Porto Alegre, RS, Brazil., Ferreira D; Otus Solutions, Porto Alegre, RS, Brazil., Kunkel NT; Research Institute, HMV, Porto Alegre, RS, Brazil., Camargo NI; Research Institute, HMV, Porto Alegre, RS, Brazil., Sarturi JC; Research Institute, HMV, Porto Alegre, RS, Brazil., Guilhem MC; Research Institute, HMV, Porto Alegre, RS, Brazil., de Oliveira JC; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Lopes CC; Research Institute, HMV, Porto Alegre, RS, Brazil., Widmar F; Research Institute, HMV, Porto Alegre, RS, Brazil., Barufi LK; Research Institute, HMV, Porto Alegre, RS, Brazil., da Silva GN; Research Institute, HMV, Porto Alegre, RS, Brazil., Gradia DF; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Brandalize APC; Faculty of Medicine, Campus Toledo, Federal University of Paraná (UFPR), Brazil., Royer CA; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Luiz RM; Faculty of Medicine, Campus Toledo, Federal University of Paraná (UFPR), Brazil., Baura VA; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Abreu H; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Poitevin CG; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Kucharski GA; Department of Health of Toledo, Toledo, PR, Brazil., Pedrotti F; Department of Health of Toledo, Toledo, PR, Brazil., Valluri SR; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Srivastava A; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA; Orbital Therapeutics, Cambridge MA, USA., Julião VW; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Melone OC; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Allen KE; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Kyaw MH; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Castillo GDCM; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., McLaughlin JM; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA. |
| Corporate Authors: | Toledo BNT162b2 Study Group Investigators |
| Source: | Immunology letters [Immunol Lett] 2024 Oct; Vol. 269, pp. 106903. Date of Electronic Publication: 2024 Jul 26. |
| Publication Type: | Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7910006 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0542 (Electronic) Linking ISSN: 01652478 NLM ISO Abbreviation: Immunol Lett Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39069096 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-world effectiveness of original BNT162b2 mRNA COVID-19 against symptomatic Omicron infection among children 5-11 years of age in Brazil: A prospective test-negative design study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rodrigues+CO%22">Rodrigues CO</searchLink>; Faculty of Medicine, Campus Toledo, Federal University of Paraná (UFPR), Brazil.<br /><searchLink fieldCode="AU" term="%22Spinardi+J%22">Spinardi J</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Rosa+RG%22">Rosa RG</searchLink>; Internal Medicine Department, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil; Research Unit, Inova Medical, Porto Alegre, RS, Brazil; Research Institute, HMV, Porto Alegre, RS, Brazil. Electronic address: regisgoulartrosa@gmail.com.<br /><searchLink fieldCode="AU" term="%22Falavigna+M%22">Falavigna M</searchLink>; Research Unit, Inova Medical, Porto Alegre, RS, Brazil; Research Institute, HMV, Porto Alegre, RS, Brazil; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22de+Souza+EM%22">de Souza EM</searchLink>; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil.<br /><searchLink fieldCode="AU" term="%22Manfio+JL%22">Manfio JL</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22de+Souza+AP%22">de Souza AP</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22de+Araujo+CLP%22">de Araujo CLP</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Cohen+M%22">Cohen M</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil; Federal University of Rio Grande do Sul (UFRGS), Brazil.<br /><searchLink fieldCode="AU" term="%22Barbosa+GRGDV%22">Barbosa GRGDV</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Silva+FKR%22">Silva FKR</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Sganzerla+D%22">Sganzerla D</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22da+Silva+MMD%22">da Silva MMD</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Ferreira+D%22">Ferreira D</searchLink>; Otus Solutions, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Kunkel+NT%22">Kunkel NT</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Camargo+NI%22">Camargo NI</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Sarturi+JC%22">Sarturi JC</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Guilhem+MC%22">Guilhem MC</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22de+Oliveira+JC%22">de Oliveira JC</searchLink>; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil.<br /><searchLink fieldCode="AU" term="%22Lopes+CC%22">Lopes CC</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Widmar+F%22">Widmar F</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Barufi+LK%22">Barufi LK</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22da+Silva+GN%22">da Silva GN</searchLink>; Research Institute, HMV, Porto Alegre, RS, Brazil.<br /><searchLink fieldCode="AU" term="%22Gradia+DF%22">Gradia DF</searchLink>; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil.<br /><searchLink fieldCode="AU" term="%22Brandalize+APC%22">Brandalize APC</searchLink>; Faculty of Medicine, Campus Toledo, Federal University of Paraná (UFPR), Brazil.<br /><searchLink fieldCode="AU" term="%22Royer+CA%22">Royer CA</searchLink>; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil.<br /><searchLink fieldCode="AU" term="%22Luiz+RM%22">Luiz RM</searchLink>; Faculty of Medicine, Campus Toledo, Federal University of Paraná (UFPR), Brazil.<br /><searchLink fieldCode="AU" term="%22Baura+VA%22">Baura VA</searchLink>; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil.<br /><searchLink fieldCode="AU" term="%22Abreu+H%22">Abreu H</searchLink>; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil.<br /><searchLink fieldCode="AU" term="%22Poitevin+CG%22">Poitevin CG</searchLink>; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil.<br /><searchLink fieldCode="AU" term="%22Kucharski+GA%22">Kucharski GA</searchLink>; Department of Health of Toledo, Toledo, PR, Brazil.<br /><searchLink fieldCode="AU" term="%22Pedrotti+F%22">Pedrotti F</searchLink>; Department of Health of Toledo, Toledo, PR, Brazil.<br /><searchLink fieldCode="AU" term="%22Valluri+SR%22">Valluri SR</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Srivastava+A%22">Srivastava A</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA; Orbital Therapeutics, Cambridge MA, USA.<br /><searchLink fieldCode="AU" term="%22Julião+VW%22">Julião VW</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Melone+OC%22">Melone OC</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Allen+KE%22">Allen KE</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kyaw+MH%22">Kyaw MH</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Castillo+GDCM%22">Castillo GDCM</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22McLaughlin+JM%22">McLaughlin JM</searchLink>; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Toledo+BNT162b2+Study+Group+Investigators%22">Toledo BNT162b2 Study Group Investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227910006%22">Immunology letters</searchLink> [Immunol Lett] 2024 Oct; Vol. 269, pp. 106903. <i>Date of Electronic Publication: </i>2024 Jul 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2FNorth-Holland+Biomedical+Press%22">Elsevier/North-Holland Biomedical Press </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>7910006 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0542 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201652478%22">01652478 </searchLink><i>NLM ISO Abbreviation: </i>Immunol Lett <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39069096 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.imlet.2024.106903 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 106903 Titles: – TitleFull: Real-world effectiveness of original BNT162b2 mRNA COVID-19 against symptomatic Omicron infection among children 5-11 years of age in Brazil: A prospective test-negative design study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rodrigues CO – PersonEntity: Name: NameFull: Spinardi J – PersonEntity: Name: NameFull: Rosa RG – PersonEntity: Name: NameFull: Falavigna M – PersonEntity: Name: NameFull: de Souza EM – PersonEntity: Name: NameFull: Manfio JL – PersonEntity: Name: NameFull: de Souza AP – PersonEntity: Name: NameFull: de Araujo CLP – PersonEntity: Name: NameFull: Cohen M – PersonEntity: Name: NameFull: Barbosa GRGDV – PersonEntity: Name: NameFull: Silva FKR – PersonEntity: Name: NameFull: Sganzerla D – PersonEntity: Name: NameFull: da Silva MMD – PersonEntity: Name: NameFull: Ferreira D – PersonEntity: Name: NameFull: Kunkel NT – PersonEntity: Name: NameFull: Camargo NI – PersonEntity: Name: NameFull: Sarturi JC – PersonEntity: Name: NameFull: Guilhem MC – PersonEntity: Name: NameFull: de Oliveira JC – PersonEntity: Name: NameFull: Lopes CC – PersonEntity: Name: NameFull: Widmar F – PersonEntity: Name: NameFull: Barufi LK – PersonEntity: Name: NameFull: da Silva GN – PersonEntity: Name: NameFull: Gradia DF – PersonEntity: Name: NameFull: Brandalize APC – PersonEntity: Name: NameFull: Royer CA – PersonEntity: Name: NameFull: Luiz RM – PersonEntity: Name: NameFull: Baura VA – PersonEntity: Name: NameFull: Abreu H – PersonEntity: Name: NameFull: Poitevin CG – PersonEntity: Name: NameFull: Kucharski GA – PersonEntity: Name: NameFull: Pedrotti F – PersonEntity: Name: NameFull: Valluri SR – PersonEntity: Name: NameFull: Srivastava A – PersonEntity: Name: NameFull: Julião VW – PersonEntity: Name: NameFull: Melone OC – PersonEntity: Name: NameFull: Allen KE – PersonEntity: Name: NameFull: Kyaw MH – PersonEntity: Name: NameFull: Castillo GDCM – PersonEntity: Name: NameFull: McLaughlin JM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2024 Oct Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1879-0542 Numbering: – Type: volume Value: 269 Titles: – TitleFull: Immunology letters Type: main |
| ResultId | 1 |